BriaCell Therapeutics Short Interest Ratio and Short Volume

-0.08 (-1.32 %)
(As of 02/23/2021)
Today's Range
Now: $5.95
50-Day Range
MA: $5.30
52-Week Range
Now: $5.95
Volume2,000 shs
Average Volume1,859 shs
Market Capitalization$4.59 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

BriaCell Therapeutics (OTCMKTS:BCTXF) Short Interest Data

Current Short Volume1,200 shares
Previous Short Volume200 shares
Change Vs. Previous Month:+500.00%
Dollar Volume Sold Short$5,400.00
Short Interest Ratio / Days to Cover0.7
Last Record DateFebruary, 12 2021
Outstanding Shares772,000 shares
Percentage of Shares Shorted0.16%
Today's Trading Volume2,000 shares
Average Trading Volume1,859 shares
Today's Volume Vs. Average7.58%

Short Interest Over Time

BriaCell Therapeutics (OTCMKTS:BCTXF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20211,200 shares $5,400.00 +500.0%N/A0.7 $4.50
1/29/2021200 shares $950.00 -33.3%N/A0.3 $4.75
1/15/2021300 shares $1,629.00 +50.0%N/A0.1 $5.43
12/31/2020300 shares $1,225.50 +50.0%N/A0.1 $4.08
12/15/2020300 shares $1,131.00 +50.0%N/A0.1 $3.77
11/30/2020200 shares $768.00 -77.8%N/A0.5 $3.84
11/15/2020900 shares $3,321.00 +50.0%N/A0.9 $3.69
10/30/2020600 shares $2,394.00 +100.0%N/A0.7 $3.99
10/15/2020300 shares $1,239.00 No ChangeN/A3 $4.13
9/30/2020300 shares $975.00 No ChangeN/A0.6 $3.25
9/15/2020300 shares $1,293.00 No ChangeN/A0.8 $4.31

BriaCell Therapeutics (OTCMKTS:BCTXF) Short Interest FAQ

speech bubbles
speech bubbles

What is BriaCell Therapeutics' current short interest?

Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, traders have sold 1,200 shares of BCTXF short.

What is a good short interest ratio for BriaCell Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BriaCell Therapeutics currently has a short interest ratio of 1.0.

Is BriaCell Therapeutics' short interest increasing or decreasing?

BriaCell Therapeutics saw a increase in short interest in February. As of February 12th, there was short interest totaling 1,200 shares, an increase of 500.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BriaCell Therapeutics' short interest compare to its competitors?

0.00% of BriaCell Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BriaCell Therapeutics: Artelo Biosciences, Inc. (0.00%), Sonoma Pharmaceuticals, Inc. (0.93%), Bioxytran, Inc. (0.00%), Xenetic Biosciences Inc (2.59%), XTL Biopharmaceuticals Ltd. (0.00%), Intec Pharma Ltd (14.53%), Medicure Inc. (0.00%), CannaPharmaRX, Inc. (0.00%), iCo Therapeutics Inc. (0.00%), and Teligent, Inc. (0.71%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short BriaCell Therapeutics stock?

Short selling BCTXF is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BriaCell Therapeutics' stock is trading down $0.08 today. To short BriaCell Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that BriaCell Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BriaCell Therapeutics?

A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTXF, which in turn drives the price of the stock up even further.

How often is BriaCell Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTXF, twice per month. The most recent reporting period available is February, 12 2021.

This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.